List of Excipients in API sacubitril and valsartan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sacubitril and valsartan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | FERROSOFERRIC OXIDE | |
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | |
| Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | HYPROMELLOSES | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing sacubitril and valsartan
Detailed excipient profiles for sacubitril and valsartan
Excipient focus: AMMONIA
sacubitril and valsartan drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing AMMONIA
Excipient focus: CALCIUM CARBONATE
sacubitril and valsartan drug variants containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing CALCIUM CARBONATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sacubitril and valsartan drug variants containing CELLULOSE, MICROCRYSTALLINE
sacubitril and valsartan drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
sacubitril and valsartan drug variants containing CROSCARMELLOSE SODIUM
sacubitril and valsartan drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
sacubitril and valsartan drug variants containing CROSPOVIDONE
sacubitril and valsartan drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | sacubitril and valsartan | 0904-7580 |
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-707 |
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-949 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIACETYLATED MONOGLYCERIDES
sacubitril and valsartan drug variants containing DIACETYLATED MONOGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | sacubitril and valsartan | 31722-673 |
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing DIACETYLATED MONOGLYCERIDES
Excipient focus: FERRIC OXIDE RED
sacubitril and valsartan drug variants containing FERRIC OXIDE RED
sacubitril and valsartan drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
sacubitril and valsartan drug variants containing FERRIC OXIDE YELLOW
sacubitril and valsartan drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
sacubitril and valsartan drug variants containing FERROSOFERRIC OXIDE
sacubitril and valsartan drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
sacubitril and valsartan drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sacubitril and valsartan | 60687-955 |
| Novugen Pharma (USA) LLC | sacubitril and valsartan | 82293-027 |
| Novugen Pharma (USA) LLC | sacubitril and valsartan | 82293-040 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
sacubitril and valsartan drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Biocon Pharma Inc | sacubitril and valsartan | 70377-031 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
sacubitril and valsartan drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
sacubitril and valsartan drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYDROXYPROPYLCELLULOSE
sacubitril and valsartan drug variants containing HYDROXYPROPYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | sacubitril and valsartan | 69238-2731 |
| AvKARE | sacubitril and valsartan | 73190-017 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing HYDROXYPROPYLCELLULOSE
Excipient focus: HYPROMELLOSE
sacubitril and valsartan drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| Alembic Pharmaceuticals Limited | sacubitril and valsartan | 46708-556 |
| Alembic Pharmaceuticals Inc | sacubitril and valsartan | 62332-556 |
| Coupler LLC | sacubitril and valsartan | 67046-1624 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
sacubitril and valsartan drug variants containing HYPROMELLOSE 2910
sacubitril and valsartan drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
sacubitril and valsartan drug variants containing HYPROMELLOSES
sacubitril and valsartan drug variants not containing HYPROMELLOSES
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
sacubitril and valsartan drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Camber Pharmaceuticals Inc | sacubitril and valsartan | 31722-673 |
| Laurus Labs Limited | sacubitril and valsartan | 42385-930 |
| American Health Packaging | sacubitril and valsartan | 60687-955 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
sacubitril and valsartan drug variants containing MAGNESIUM STEARATE
sacubitril and valsartan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | sacubitril and valsartan | 70710-1272 |
| Zydus Lifesciences Limited | sacubitril and valsartan | 70771-1921 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
sacubitril and valsartan drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | sacubitril and valsartan | 70748-195 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
sacubitril and valsartan drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | sacubitril and valsartan | 70710-1272 |
| Zydus Lifesciences Limited | sacubitril and valsartan | 70771-1921 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
sacubitril and valsartan drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| Zydus Pharmaceuticals USA Inc | sacubitril and valsartan | 70710-1272 |
| Zydus Lifesciences Limited | sacubitril and valsartan | 70771-1921 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
sacubitril and valsartan drug variants containing MICROCRYSTALLINE CELLULOSE 112
sacubitril and valsartan drug variants not containing MICROCRYSTALLINE CELLULOSE 112
Excipient focus: POLYETHYLENE GLYCOL
sacubitril and valsartan drug variants containing POLYETHYLENE GLYCOL
sacubitril and valsartan drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
sacubitril and valsartan drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | sacubitril and valsartan | 70748-195 |
| NorthStar RxLLC | sacubitril and valsartan | 72603-880 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
sacubitril and valsartan drug variants containing POLYETHYLENE GLYCOL 4000
sacubitril and valsartan drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
sacubitril and valsartan drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | sacubitril and valsartan | 70710-1272 |
| Zydus Lifesciences Limited | sacubitril and valsartan | 70771-1921 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
sacubitril and valsartan drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
sacubitril and valsartan drug variants containing POLYVINYL ALCOHOL
sacubitril and valsartan drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE K30
sacubitril and valsartan drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | sacubitril and valsartan | 13668-634 |
| Camber Pharmaceuticals Inc | sacubitril and valsartan | 31722-673 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
sacubitril and valsartan drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
sacubitril and valsartan drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
sacubitril and valsartan drug variants containing SILICON DIOXIDE
sacubitril and valsartan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
sacubitril and valsartan drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | sacubitril and valsartan | 60687-955 |
| Biocon Pharma Inc | sacubitril and valsartan | 70377-031 |
| Novugen Pharma (USA) LLC | sacubitril and valsartan | 82293-027 |
| Novugen Pharma (USA) LLC | sacubitril and valsartan | 82293-040 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
sacubitril and valsartan drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | sacubitril and valsartan | 0904-7580 |
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-707 |
| Ascend Laboratories LLC | sacubitril and valsartan | 67877-949 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
sacubitril and valsartan drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | sacubitril and valsartan | 70710-1272 |
| Zydus Lifesciences Limited | sacubitril and valsartan | 70771-1921 |
| >Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: TALC
sacubitril and valsartan drug variants containing TALC
sacubitril and valsartan drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
sacubitril and valsartan drug variants containing TITANIUM DIOXIDE
sacubitril and valsartan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | sacubitril and valsartan | 43598-643 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links